OBJECTIVES: To determine the disease burden, measured by resource utilization, of four urologic conditions among veteran users of U.S. Department of Veterans Affairs (VA) healthcare services and to assess variations by selected sociodemographic characteristics. METHODS: We applied expert-derived diagnosis clusters to establish four patient cohorts from a population of U.S. veterans aged 18 years and older with at least one outpatient visit in a VA healthcare facility in fiscal year 2001 (n = 3,691,519): (1) benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS), (2) kidney stones (KS), (3) urinary tract infections (UTI), and (4) urinary incontinence (UI). We identified patients with qualifying diagnosis codes associated with outpatient visits in the national VA Outpatient Clinic file, thereby generating case counts for each diagnostic category. RESULTS: Among veteran users of VA healthcare services, when defined as the primary reason for the visit, the prevalence of BPH/LUTS was 4811 per 100,000 veterans (4.8%); the prevalence of KS was 597 per 100,000 (0.6%); the prevalence of UTI was 4265 and 1719 per 100,000 female and male veterans, respectively (4.3% and 1.7%); and the prevalence of UI was 2161 and 515 per 100,000 female and male veterans, respectively (2.2% and 0.5%). Prevalence of these conditions when ascertained by capturing diagnoses appearing as secondary reasons for a physician visit was much higher. CONCLUSIONS: Although we expected the prevalence of urologic conditions to be high among veterans who use the VA system for care, we found the burden of urologic disease among veterans to be comparable to other national data sets. Prevalence estimates based on primary diagnosis, rather than secondary or "any" diagnosis, significantly underestimated the disease burden among veterans.
OBJECTIVES: To determine the disease burden, measured by resource utilization, of four urologic conditions among veteran users of U.S. Department of Veterans Affairs (VA) healthcare services and to assess variations by selected sociodemographic characteristics. METHODS: We applied expert-derived diagnosis clusters to establish four patient cohorts from a population of U.S. veterans aged 18 years and older with at least one outpatient visit in a VA healthcare facility in fiscal year 2001 (n = 3,691,519): (1) benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS), (2) kidney stones (KS), (3) urinary tract infections (UTI), and (4) urinary incontinence (UI). We identified patients with qualifying diagnosis codes associated with outpatient visits in the national VA Outpatient Clinic file, thereby generating case counts for each diagnostic category. RESULTS: Among veteran users of VA healthcare services, when defined as the primary reason for the visit, the prevalence of BPH/LUTS was 4811 per 100,000 veterans (4.8%); the prevalence of KS was 597 per 100,000 (0.6%); the prevalence of UTI was 4265 and 1719 per 100,000 female and male veterans, respectively (4.3% and 1.7%); and the prevalence of UI was 2161 and 515 per 100,000 female and male veterans, respectively (2.2% and 0.5%). Prevalence of these conditions when ascertained by capturing diagnoses appearing as secondary reasons for a physician visit was much higher. CONCLUSIONS: Although we expected the prevalence of urologic conditions to be high among veterans who use the VA system for care, we found the burden of urologic disease among veterans to be comparable to other national data sets. Prevalence estimates based on primary diagnosis, rather than secondary or "any" diagnosis, significantly underestimated the disease burden among veterans.
Authors: Jennifer T Anger; Christopher S Saigal; Lynn Stothers; David H Thom; Larissa V Rodríguez; Mark S Litwin Journal: J Urol Date: 2006-11 Impact factor: 7.450
Authors: William H Rogers; Lewis E Kazis; Donald R Miller; Katherine M Skinner; Jack A Clark; Avron Spiro; R Graeme Fincke Journal: J Ambul Care Manage Date: 2004 Jul-Sep
Authors: Aruna V Sarma; John T Wei; Debra J Jacobson; Rodney L Dunn; Rosebud O Roberts; Cynthia J Girman; Michael M Lieber; Kathleen A Cooney; David Schottenfeld; James E Montie; Steven J Jacobsen Journal: Urology Date: 2003-06 Impact factor: 2.649
Authors: Joseph T Hanlon; Subashan Perera; Paul J Drinka; Christopher J Crnich; Steven J Schweon; Michele Klein-Fedyshin; Charles B Wessel; Stacey Saracco; Gulsum Anderson; Mary Mulligan; David A Nace Journal: J Am Geriatr Soc Date: 2018-12-24 Impact factor: 5.562
Authors: Michael Fenstermaker; Sujay Paknikar; Amarnath Rambhatla; Dana A Ohl; Ted A Skolarus; James M Dupree Journal: Curr Urol Rep Date: 2017-09-18 Impact factor: 3.092
Authors: Aylin Colpan; Brian Johnston; Stephen Porter; Connie Clabots; Ruth Anway; Lao Thao; Michael A Kuskowski; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson Journal: Clin Infect Dis Date: 2013-08-06 Impact factor: 9.079
Authors: Katia J Bruxvoort; Zoe Bider-Canfield; Joan A Casey; Lei Qian; Alice Pressman; Anna S Liang; Sarah Robinson; Steven J Jacobsen; Sara Y Tartof Journal: Clin Infect Dis Date: 2020-06-24 Impact factor: 9.079
Authors: Benjamin N Breyer; Beth E Cohen; Daniel Bertenthal; Raymond C Rosen; Thomas C Neylan; Karen H Seal Journal: Urology Date: 2013-10-19 Impact factor: 2.649
Authors: Elisheva R Danan; Erin E Krebs; Kristine Ensrud; Eva Koeller; Roderick MacDonald; Tina Velasquez; Nancy Greer; Timothy J Wilt Journal: J Gen Intern Med Date: 2017-09-14 Impact factor: 5.128
Authors: David A Nace; Subashan K Perera; Joseph T Hanlon; Stacey Saracco; Gulsum Anderson; Steven J Schweon; Michele Klein-Fedyshin; Charles B Wessel; Mary Mulligan; Paul J Drinka; Christopher J Crnich Journal: J Am Med Dir Assoc Date: 2018-07-20 Impact factor: 4.669